1346702-53-1

Basic information

• Product Name: Methyl 6-broMo-2-isopropyl-2H-indazole-4-carboxylate
• Synonyms: Methyl 6-broMo-2-isopropyl-2H-indazole-4-carboxylate;Methyl 6-bromo-2-(1-methylethyl)-2H-indazole-4-carboxylate;methyl 6-bromo-2-(propan-2-yl)-2H-indazole-4-carboxylate;6-Bromo-2-isopropyl-2H-indazol-4-carboxylic acid methyl ester
• CAS NO: 1346702-53-1
• Molecular Formula: C12H13BrN2O2
• Molecular Weight: 297.14782
• Mol File: 1346702-53-1.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Methyl 6-broMo-2-isopropyl-2H-indazole-4-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 6-broMo-2-isopropyl-2H-indazole-4-carboxylate(1346702-53-1)
• EPA Substance Registry System: Methyl 6-broMo-2-isopropyl-2H-indazole-4-carboxylate(1346702-53-1)

Safety Data

• Hazardous Substances Data: 1346702-53-1(Hazardous Substances Data)

Usage

General Description

Methyl 6-bromO-2-isopropyl-2H-indazole-4-carboxylate is a chemical compound with the molecular formula C13H15BrN2O2. It is an indazole derivative with a bromine substitution at the 6 position and a methyl ester group at the 4 position. Methyl 6-broMo-2-isopropyl-2H-indazole-4-carboxylate has potential applications in medicinal chemistry and pharmaceutical research, as it may exhibit biological activities and properties that could be useful in drug development. It is important to handle and use this compound with caution, as it may have hazardous properties and should only be used by trained professionals in a controlled laboratory setting.

Upstream product

• 885518-49-0 methyl 6-bromo-1H-indazole-4-carboxylate 
• 75-26-3 isopropyl bromide 

Relevant articles and documents

18F-Labeled PET Probe Targeting Enhancer of Zeste Homologue 2 (EZH2) for Cancer Imaging

The enzyme enhancer of zeste homologue 2 (EZH2) plays a catalytic role in histone methylation (H3K27me3), one of the epigenetic modifications that is dysregulated in cancer. The development of a positron emission tomography (PET) imaging agent targeting E

Identification of potent, selective, cell-Active inhibitors of the histone lysine methyltransferase EZH2

The histone H3-lysine 27 (H3K27) methyltransferase EZH2 plays a critical role in regulating gene expression, and its aberrant activity is linked to the onset and progression of cancer. As part of a drug discovery program targeting EZH2, we have identified highly potent, selective, SAM-competitive, and cell-Active EZH2 inhibitors, including GSK926 (3) and GSK343 (6). These compounds are small molecule chemical tools that would be useful to further explore the biology of EZH2.